Ligand Pharmaceuticals Statistics
Total Valuation
LGND has a market cap or net worth of $4.65 billion. The enterprise value is $4.28 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LGND has 20.04 million shares outstanding. The number of shares has increased by 9.72% in one year.
| Current Share Class | 20.04M |
| Shares Outstanding | 20.04M |
| Shares Change (YoY) | +9.72% |
| Shares Change (QoQ) | -5.94% |
| Owned by Insiders (%) | 2.34% |
| Owned by Institutions (%) | 106.65% |
| Float | 19.57M |
Valuation Ratios
The trailing PE ratio is 30.83 and the forward PE ratio is 44.30. LGND's PEG ratio is 2.33.
| PE Ratio | 30.83 |
| Forward PE | 44.30 |
| PS Ratio | 16.78 |
| Forward PS | 21.20 |
| PB Ratio | 4.61 |
| P/TBV Ratio | 6.79 |
| P/FCF Ratio | 37.43 |
| P/OCF Ratio | 37.28 |
| PEG Ratio | 2.33 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 31.81, with an EV/FCF ratio of 34.76.
| EV / Earnings | 27.85 |
| EV / Sales | 15.58 |
| EV / EBITDA | 31.81 |
| EV / EBIT | 42.25 |
| EV / FCF | 34.76 |
Financial Position
The company has a current ratio of 21.28, with a Debt / Equity ratio of 0.45.
| Current Ratio | 21.28 |
| Quick Ratio | 20.81 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 3.34 |
| Debt / FCF | 3.67 |
| Interest Coverage | 18.09 |
Financial Efficiency
Return on equity (ROE) is 17.13% and return on invested capital (ROIC) is 11.97%.
| Return on Equity (ROE) | 17.13% |
| Return on Assets (ROA) | 5.19% |
| Return on Invested Capital (ROIC) | 11.97% |
| Return on Capital Employed (ROCE) | 6.79% |
| Weighted Average Cost of Capital (WACC) | 9.33% |
| Revenue Per Employee | $5.84M |
| Profits Per Employee | $3.27M |
| Employee Count | 47 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 3.32 |
Taxes
In the past 12 months, LGND has paid $31.32 million in taxes.
| Income Tax | 31.32M |
| Effective Tax Rate | 16.94% |
Stock Price Statistics
| Beta (5Y) | 1.07 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 216.08 |
| 200-Day Moving Average | 193.43 |
| Relative Strength Index (RSI) | 57.27 |
| Average Volume (20 Days) | 229,915 |
Short Selling Information
The latest short interest is 1.46 million, so 7.26% of the outstanding shares have been sold short.
| Short Interest | 1.46M |
| Short Previous Month | 1.41M |
| Short % of Shares Out | 7.26% |
| Short % of Float | 7.44% |
| Short Ratio (days to cover) | 6.52 |
Income Statement
In the last 12 months, LGND had revenue of $274.48 million and earned $153.56 million in profits. Earnings per share was $7.50.
| Revenue | 274.48M |
| Gross Profit | 228.26M |
| Operating Income | 101.23M |
| Pretax Income | 184.88M |
| Net Income | 153.56M |
| EBITDA | 134.45M |
| EBIT | 101.23M |
| Earnings Per Share (EPS) | $7.50 |
Full Income StatementBalance Sheet
The company has $779.41 million in cash and $451.98 million in debt, with a net cash position of $327.43 million or $16.34 per share.
| Cash & Cash Equivalents | 779.41M |
| Total Debt | 451.98M |
| Net Cash | 327.43M |
| Net Cash Per Share | $16.34 |
| Equity (Book Value) | 997.32M |
| Book Value Per Share | 49.79 |
| Working Capital | 824.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $123.50 million and capital expenditures -$466,000, giving a free cash flow of $123.03 million.
| Operating Cash Flow | 123.50M |
| Capital Expenditures | -466,000 |
| Depreciation & Amortization | 33.22M |
| Net Borrowing | 346.72M |
| Free Cash Flow | 123.03M |
| FCF Per Share | $6.14 |
Full Cash Flow StatementMargins
Gross margin is 83.16%, with operating and profit margins of 36.88% and 55.95%.
| Gross Margin | 83.16% |
| Operating Margin | 36.88% |
| Pretax Margin | 67.36% |
| Profit Margin | 55.95% |
| EBITDA Margin | 48.98% |
| EBIT Margin | 36.88% |
| FCF Margin | 44.82% |
Dividends & Yields
LGND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.72% |
| Shareholder Yield | -9.72% |
| Earnings Yield | 3.34% |
| FCF Yield | 2.67% |
Analyst Forecast
The average price target for LGND is $271.80, which is 17.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $271.80 |
| Price Target Difference | 17.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 12.79% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on November 19, 2010. It was a reverse split with a ratio of 1:6.
| Last Split Date | Nov 19, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
LGND has an Altman Z-Score of 5.13 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.13 |
| Piotroski F-Score | 6 |
